Vivid Genomics
PrivateLast Round
Accelerator
Oct 25, 2018
Total Funding Raised
$20,000
Company Overview
Vivid Genomics operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was an Accelerator round in October 2018.
Vivid Genomics is a biotechnology company that develops diagnostic tests for neurodegenerative diseases.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Clinical Trials, Biotechnology, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivid Genomics Comparables
Compare Vivid Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ADmit Therapeutics | 83% | |
| Polaris Genomics | 77% | |
| C₂N Diagnostics | 77% |
For institutional investors. Book with your work email.
Vivid Genomics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Vivid Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ad Astra Ventures | Accelerator |
| Six Dragonflies | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 25, 2018
$20K round led by Ad Astra Ventures.
For institutional investors. Book with your work email.
Vivid Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Vivid Genomics's valuation, stock price, and market status.
Is Vivid Genomics a public or private company?
Vivid Genomics is a private company.
What is the current stock price of Vivid Genomics?
Vivid Genomics is a private company, so its shares have no public market price. Caplight tracks Vivid Genomics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Vivid Genomics worth (valuation)?
Valuation information for Vivid Genomics is not publicly available.
Can I buy Vivid Genomics stock?
Vivid Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Vivid Genomics's last funding round?
Vivid Genomics's most recent funding round was Accelerator on October 25, 2018.
Who are the main investors in Vivid Genomics?
Key investors in Vivid Genomics include Ad Astra Ventures.
Will Vivid Genomics IPO soon?
No public IPO plans have been announced for Vivid Genomics.
How can I track Vivid Genomics secondary market activity?
Caplight tracks bids, offers, and trades in Vivid Genomics's shares on secondary markets.